Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Duchenne UK

UK company 08030768, incorporated on 14 April 2012.

Home | Duchenne UK

Duchenne UK is the leading UK charity for Duchenne muscular dystrophy. We're going further and faster than ever before to find effective treatments for DMD.

Company number
08030768
Incorporated
14 Apr 2012
Companies House status
Active

Company identity

Founded / incorporated
14 April 2012

Company number 08030768

Verify at Companies House
Legal name
DUCHENNE UK
Company type
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
Region
Unknown
Registered address
UNIT G.24, SHEPHERD'S BUILDING
CHARECROFT WAY
LONDON
ENGLAND
W14 0EE
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
13 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

24 Aug
2026

Accounts With Accounts Type Small

Accounts PDF pending

AA | Transaction MzUzOTc4MDI3NWFkaXF6a2N4 | Paper/PDF filed

Published 24 Aug 2026 11:57

30 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

14 Apr
2012

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2024
Funded years
2024
Age at first award
11 years

Projects

2024 EU-Funded Lead participant

Patient Lifestyle and Disease Data Interactium (PaLaDIn)

1 Jan 2024 to 31 Dec 2027

Awarded
£509,487
Total cost £509,487

Neuromuscular disease is at the forefront of collecting real-world demographic and clinically-relevant data from patients. PaLaDIn, a public private partnership, will leverage TREAT-NMD's Global Registry Platform. This uses patient data to support clinical trial planning/ recruitment as well as more complex regulator-driven studies. With other Partners’ e...

Product types

EU-Funded